610 news items
Page 2 of 31
gqnzu6rl2mhw7ky0z4fal3gj00fcj008sye4q7snrvid
GRTS
SMG
17 Jun 24
, a clinical-stage biotechnology company, engages in developing vaccine-based immunotherapy candidates against cancer and infectious diseases
5ng21s4je8cpmhr4oo5v0be74btwdh6fc4
MRK
17 Jun 24
progression or death by 40% (HR=0.60 [95% CI, 0.46-0.78]; p<0.0001) in patients whose cancer was mismatch repair proficient (pMMR) and by 70% (HR=0.30 [95
mps6kywltzo9zl7tti349ybgimlls0gp7 164kq8gobzum97let517yb
BNTX
17 Jun 24
factor receptor-mutated non-small cell lung cancer or HR+/HER2-negative breast cancer.
Also Read
rc5nf35dp71uxoilmes8y5mpge0oec32dtxj cfszk0lfra2
17 Jun 24
health services, including health promotion, prevention programs, vaccination, outbreak response, One Health, and environmental health for the Israeli
ss9jokezrh 0k6tl93iw0
NWBO
17 Jun 24
DCVax® personalized immune therapies for solid tumor cancers, announced today
2jlb6c8 zc
EVAX
17 Jun 24
% objective response rate (ORR) is reported in the publication summarizing results from the Phase 1 study assessing Evaxion's personalized cancer vaccine
0tkvpjyaaxe28v4uc7zmpw6ejbpal9vcdzierntjnqaa0rxfibqknt
GRTS
17 Jun 24
@bernlieb.com. Gritstone is a clinical-stage biotechnology company that engages in developing vaccine-based
7xa4m6uxrdomqatzl9nal rtvu08625fw6oojfxj5ke2d
GRTS
17 Jun 24
that develops vaccine-based immunotherapy candidates against cancer and infectious diseases
h3ybzjmmwmvbyz2 zw4tlwofzjwpjvhhnw
GRTS
17 Jun 24
:
According to the Complaint, Gritstone is a clinical-stage biotechnology company that develops vaccine-based
1mby1ii8nbsf83ey93ckqe48cmu1lccc4wm7qlx9f7 wtd9gklh8
AZN
16 Jun 24
, Puddin Clarke Endowed Professor, Director of Mantle Cell Lymphoma Program of Excellence, Co-Director of Clinical Trials at MD Anderson Cancer Center
wqd0mq2r00fi1mguki778ftyezp282enpn876i1mg0
GRTS
15 Jun 24
]
Gritstone, a clinical-stage biotechnology company, engages in developing vaccine-based immunotherapy candidates against cancer and infectious
gd9vwhw5cxvh6utfdbvu5tkl0m1i3xl31c8yzkbbs49jrcahpny7z1py7b72
14 Jun 24
to manufacturers of COVID-19 vaccines (2024-2025 Formula). The FDA initially advised the manufacturers of the licensed and authorized COVID-19 vaccines
1lte29dyul01kcj lo6lbwzdaq0ryv3l1viytja6410i
AMGN
14 Jun 24
, regardless of measurable residual disease (MRD) status.
"B-ALL is an aggressive blood cancer
jfr79hjdumz2nprx2nrgd9q1qf7xdlfcipuwox q9avu7bjyeei53d6
MRK
14 Jun 24
areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor
jooploiklj xhwdcn6mbbqj3m
14 Jun 24
the importance of preventive care and cancer screenings for men
Healthfirst, New York's largest not-for-profit
mojvoqmcg7nrqz
GRTS
14 Jun 24
vaccine-based immunotherapy candidates against cancer and infectious diseases. For more information, submit
0b1o4ucoablg6sve82zzv38oju2ap2ag62xa8i
TAK
14 Jun 24
), which is currently in development for chronic myeloid leukemia (CML) and other hematological cancers. If exercised, the option would allow Takeda
336rgohrmmkx9hjjikvkwt1y xp3po
SNGX
14 Jun 24
subunit vaccine technology, including SuVax™ and MarVax™, to be discussed alongside mRNA and viral vectored vaccine approaches
7a1b3c6vukwtph mpznu3g3j4eme82i7e7a9bap8vpiovchv9d0c
GILD
14 Jun 24
cancers," said Ibrahim Elhoussieny, Vice President, Medical Affairs, Kite. "These new data support the potential benefit of utilizing Yescarta in earlier
e9s871d75fyj3pers5x0zpnj kca67r7neliiieublroek7auyos
PFE
14 Jun 24
investigating elranatamab treatment with other anti-cancer therapies